Cargando…
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer
BACKGROUND: Estrogen receptor (ER)-negative breast cancer specimens are predominantly of high grade, have frequent p53 mutations, and are broadly divided into HER2-positive and basal subtypes. Although ER-negative disease has overall worse prognosis than does ER-positive breast cancer, not all ER-ne...
Autores principales: | Teschendorff, Andrew E, Miremadi, Ahmad, Pinder, Sarah E, Ellis, Ian O, Caldas, Carlos |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374988/ https://www.ncbi.nlm.nih.gov/pubmed/17683518 http://dx.doi.org/10.1186/gb-2007-8-8-r157 |
Ejemplares similares
-
A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer
por: Teschendorff, Andrew E, et al.
Publicado: (2008) -
High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer
por: Chin, Suet F, et al.
Publicado: (2007) -
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype
por: Blenkiron, Cherie, et al.
Publicado: (2007) -
Prognostic gene network modules in breast cancer hold promise
por: Teschendorff, Andrew E, et al.
Publicado: (2010) -
Pathological validation and significance of micrometastasis in sentinel nodes in primary breast cancer
por: Rampaul, Rajendra S, et al.
Publicado: (2001)